Open access
Oct 2026
HALP is a novel marker for predicting overall survival in patients with malignant soft tissue sarcoma: a retrospective study.
BACKGROUND Malignant soft tissue sarcomas (STSs) are rare, aggressive tumors with diverse subtypes and variable prognoses. Current prognostic markers, such as tumor size and grade, do not sufficiently predict postoperative outcomes. Therefore, this study aimed to assess the prognostic significance of the hemoglobin, al...
Seiji Shimomura, R. Terauchi, T. Shirai et al.
· Japanese Journal of Clinical... · 0 citations